(RDHL) Redhill Biopharma complete technical analysis [charts+indicators] | Buy/Sell Redhill Biopharma | (RDHL) share price targets
Complete technical analysis of Redhill Biopharma (RDHL) by charts plus indicators, forecast predictions and share price targets for Redhill Biopharma (RDHL)
Redhill Biopharma trades in USA in Health Care sector.
10 day averaged volume of Redhill Biopharma is 2627922
| Date | Daily Closing Price | Open | High | Low | Volume |
| 16 Fri Jan 2026 | 1.36 | 1.27 | 1.39 | 1.27 | 0.033 times |
| 15 Thu Jan 2026 | 1.31 | 1.20 | 1.33 | 1.20 | 0.039 times |
| 14 Wed Jan 2026 | 1.23 | 1.25 | 1.25 | 1.21 | 0.022 times |
| 13 Tue Jan 2026 | 1.24 | 1.26 | 1.26 | 1.20 | 0.008 times |
| 12 Mon Jan 2026 | 1.27 | 1.25 | 1.28 | 1.17 | 0.059 times |
| 09 Fri Jan 2026 | 1.28 | 1.37 | 1.37 | 1.25 | 0.021 times |
| 08 Thu Jan 2026 | 1.32 | 1.22 | 1.38 | 1.22 | 0.084 times |
| 07 Wed Jan 2026 | 1.22 | 1.31 | 1.38 | 1.21 | 0.112 times |
| 06 Tue Jan 2026 | 1.39 | 1.32 | 1.41 | 1.27 | 0.242 times |
| 05 Mon Jan 2026 | 1.40 | 1.20 | 1.42 | 1.19 | 9.398 times |
My analysis of stock is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if stock stays above 1.3, but if it comes below 1.3, then a intra day sell could be more profitable.
If you take a sell trade below 1.3, then use 1.3 as stoploss and 1.21 as target. However if you take a buy trade in stock , then use 1.3 as stoploss and 1.5 as target.
Share price targets for Redhill Biopharma (RDHL)
| Target Type | Value |
| Downside Target | 0.91 |
| Downside Target | 1.01 |
| Downside Target | 1.10 |
| Downside Target | 1.14 |
| Downside Target | 1.22 |
| Downside Target | 1.30 |
| Upside Target | 1.39 |
| Upside Target | 1.42 |
| Upside Target | 1.68 |
| Upside Target | 2.79 |
| Upside Target | 3.04 |
Intraday share price targets for Redhill Biopharma (RDHL)
| Target Type | Value |
| Downside Intraday Target | 1.22 |
| Downside Intraday Target | 1.09 |
| Upside Intraday Target | 1.44 |
| Upside Intraday Target | 1.53 |
| Downside Intraday Target | 1.31 |
Weekly technical analysis of Redhill Biopharma (RDHL)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 16 Fri Jan 2026 | 1.36 | 1.25 | 1.39 | 1.17 | 0.016 times |
| 09 Fri Jan 2026 | 1.28 | 1.20 | 1.42 | 1.19 | 55.642 times |
| 02 Fri Jan 2026 | 1.03 | 1.11 | 1.15 | 0.91 | 1.45 times |
| 26 Fri Dec 2025 | 1.14 | 1.14 | 1.23 | 1.10 | 0.904 times |
| 19 Fri Dec 2025 | 1.18 | 1.22 | 1.24 | 1.14 | 1.648 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Redhill Biopharma (RDHL)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 16 Fri Jan 2026 | 1.36 | 1.04 | 1.42 | 1.02 | 15.853 times |
| 31 Wed Dec 2025 | 1.03 | 1.20 | 1.26 | 0.91 | 0.058 times |
| 28 Fri Nov 2025 | 1.20 | 1.24 | 1.68 | 1.01 | 1.116 times |
| 31 Fri Oct 2025 | 1.30 | 2.23 | 3.04 | 1.30 | 0.446 times |
Scroll below to view daily charts
Price has moved up this month, and volume has increased substantially. This means that the move can continue in coming months.
Indicators analysis of Redhill Biopharma (RDHL)
Price action analysis of Redhill Biopharma ( (RDHL) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Redhill Biopharma ( (RDHL) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Redhill Biopharma ( (RDHL) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Redhill Biopharma ( (RDHL) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Redhill Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Redhill Biopharma in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Redhill Biopharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Redhill Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Redhill Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.4 and Redhill Biopharma (RDHL) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Redhill Biopharma (RDHL) stock. Volume based technical analysis of Redhill Biopharma (RDHL) stock is negative.
Redhill Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Redhill Biopharma ( (RDHL) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Redhill Biopharma ( (RDHL) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Redhill Biopharma ( (RDHL) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Redhill Biopharma ( (RDHL) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Redhill Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Redhill Biopharma in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Redhill Biopharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Redhill Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Redhill Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.4 and Redhill Biopharma (RDHL) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Redhill Biopharma (RDHL) stock. Volume based technical analysis of Redhill Biopharma (RDHL) stock is negative.
Redhill Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.